OOIR: Observatory of International Research

Papers

(The H4-Index of Cephalalgia is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
International Classification of Headache Disorders-4 – Work in Progress 1	124
Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials	123
Predictive value of preoperative white and gray matter microstructural alterations for microvascular decompression outcome in classical trigeminal neuralgia	95
A missing piece in the puzzle of chronic dizziness: Dysautonomia	91
A reply, drug-induced reversible cerebral vasoconstriction syndrome: Lessons from the real world	79
Efficacy of different cannabinoid compounds on migraine-like responses in female rats	65
Corticosteroid-dependent increased expression of CGRP and its receptor subunits within the rodent trigeminal ganglion does not prompt cephalic allodynia	53
Visual snow vs. migraine aura: Debate summary and novel insights into the syndrome	50
Harassment in the headache field: a global web-based cross-sectional survey	50
Genetic characterization of the endocannabinoid system and psychiatric features in patients with migraine and medication overuse headache	49
Introducing the four dimensions 4D migraine scale: A composite score proposal evaluating migraine severity and treatment efficacy	49
Persistent idiopathic facial pain: Integrating headache neurology insights into interdisciplinary guidelines	45
Chronic Migraine Epidemiology and Outcomes – International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and care	45
Evidence-based guidelines for the pharmacological treatment of migraine	44
Impact of psychiatric comorbidity, resilience and executive function on childhood and adolescent headaches: A narrative review	43
Painful nervus intermedius neuropathy attributed to Bell's palsy: The need for independent diagnostic criteria	43
Comment on “What predicts citation counts and translational impact in headache research? A machine learning analysis”	42
Triptan non-response in a London tertiary headache centre: What can we learn? A retrospective study	42
Guidelines of the International Headache Society for controlled trials of pharmacological preventive treatment for persistent post-traumatic headache attributed to mild traumatic brain injury	41
IHC 2025 late-breaking abstracts	40
Depression screening in migraine - A double-edged sword	40
Corrigendum to: Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex	39
Childhood and adolescent headache: A problem not to be ignored in the era of new therapies	39
Genome-wide DNA methylation analysis in an antimigraine-treated preclinical model of cortical spreading depolarization	38
History of maternal migraine and its association with preeclampsia: A case–control study in a low-resource setting in Sudan, Africa	36

Systemic lupus erythematosus mimicking retinal migraine: a case report	36
An altered reward system characterizes chronic migraine with medication overuse headache	36
A 7-year retrospective analysis of the management of children with acute headache presenting in a pediatric emergency department	35
2025 Highlights in migraine prevention	35
Effect of Altmetric score on manuscript citations: A randomized-controlled trial	32
Rethinking migraine with aura: Why cortical spreading depolarization (depression), not aura, causes headaches	31
Rethinking Burning Mouth Syndrome: Toward a multidimensional classification of oral dysaesthetic and perceptual disorders in ICHD-4	31
Paroxysmal hemicrania and hemicrania continua: Review on pathophysiology, clinical features and treatment	31